Alpha Galactosidase A Market, Global Outlook and Forecast 2022-2028

Alpha Galactosidase A Market, Global Outlook and Forecast 2022-2028

Report Code: KNJ1281507 | No. of Pages: 73 | Category: Pharmaceuticals and Healthcare
Publisher: Market Monitor Global | Date of Publish: Apr-2022
This report contains market size and forecasts of Alpha Galactosidase A in global, including the following market information:
Global Alpha Galactosidase A Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Alpha Galactosidase A Market Sales, 2017-2022, 2023-2028, (K Pcs)
Global top five Alpha Galactosidase A companies in 2021 (%)
The global Alpha Galactosidase A market was valued at  million in 2021 and is projected to reach US$  million by 2028, at a CAGR of  % during the forecast period.
The U.S. Market is Estimated at $  Million in 2021, While China is Forecast to Reach $  Million by 2028.
Agalsidase Alfa Segment to Reach $  Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Alpha Galactosidase A include Amicus Therapeutics, Inc., Greenovation Biotech GmbH, iBio, Inc., ISU ABXIS Co.,Ltd., JCR Pharmaceuticals Co., Ltd., Pharming Group N.V., Protalix BioTherapeutics, Inc. and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Alpha Galactosidase A manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Alpha Galactosidase A Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alpha Galactosidase A Market Segment Percentages, by Type, 2021 (%)
    Agalsidase Alfa
    AVRRD-01
    Migalastat Hydrochloride
    MOSS-AGAL
    Others
Global Alpha Galactosidase A Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alpha Galactosidase A Market Segment Percentages, by Application, 2021 (%)
    Hospital
    Clinic
    Home Care
Global Alpha Galactosidase A Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Pcs)
Global Alpha Galactosidase A Market Segment Percentages, By Region and Country, 2021 (%)
    North America
        US
        Canada
        Mexico
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
        Nordic Countries
        Benelux
        Rest of Europe
    Asia
        China
        Japan
        South Korea
        Southeast Asia
        India
        Rest of Asia
    South America
        Brazil
        Argentina
        Rest of South America
    Middle East & Africa
        Turkey
        Israel
        Saudi Arabia
        UAE
        Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Alpha Galactosidase A revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Alpha Galactosidase A revenues share in global market, 2021 (%)
Key companies Alpha Galactosidase A sales in global market, 2017-2022 (Estimated), (K Pcs)
Key companies Alpha Galactosidase A sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
    Amicus Therapeutics, Inc.
    Greenovation Biotech GmbH
    iBio, Inc.
    ISU ABXIS Co.,Ltd.
    JCR Pharmaceuticals Co., Ltd.
    Pharming Group N.V.
    Protalix BioTherapeutics, Inc.
    Takeda
1 Introduction to Research & Analysis Reports
    1.1 Alpha Galactosidase A Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Alpha Galactosidase A Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Alpha Galactosidase A Overall Market Size
    2.1 Global Alpha Galactosidase A Market Size: 2021 VS 2028
    2.2 Global Alpha Galactosidase A Revenue, Prospects & Forecasts: 2017-2028
    2.3 Global Alpha Galactosidase A Sales: 2017-2028
3 Company Landscape
    3.1 Top Alpha Galactosidase A Players in Global Market
    3.2 Top Global Alpha Galactosidase A Companies Ranked by Revenue
    3.3 Global Alpha Galactosidase A Revenue by Companies
    3.4 Global Alpha Galactosidase A Sales by Companies
    3.5 Global Alpha Galactosidase A Price by Manufacturer (2017-2022)
    3.6 Top 3 and Top 5 Alpha Galactosidase A Companies in Global Market, by Revenue in 2021
    3.7 Global Manufacturers Alpha Galactosidase A Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Alpha Galactosidase A Players in Global Market
        3.8.1 List of Global Tier 1 Alpha Galactosidase A Companies
        3.8.2 List of Global Tier 2 and Tier 3 Alpha Galactosidase A Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Alpha Galactosidase A Market Size Markets, 2021 & 2028
        4.1.2 Agalsidase Alfa
        4.1.3 AVRRD-01
        4.1.4 Migalastat Hydrochloride
        4.1.5 MOSS-AGAL
        4.1.6 Others
    4.2 By Type - Global Alpha Galactosidase A Revenue & Forecasts
        4.2.1 By Type - Global Alpha Galactosidase A Revenue, 2017-2022
        4.2.2 By Type - Global Alpha Galactosidase A Revenue, 2023-2028
        4.2.3 By Type - Global Alpha Galactosidase A Revenue Market Share, 2017-2028
    4.3 By Type - Global Alpha Galactosidase A Sales & Forecasts
        4.3.1 By Type - Global Alpha Galactosidase A Sales, 2017-2022
        4.3.2 By Type - Global Alpha Galactosidase A Sales, 2023-2028
        4.3.3 By Type - Global Alpha Galactosidase A Sales Market Share, 2017-2028
    4.4 By Type - Global Alpha Galactosidase A Price (Manufacturers Selling Prices), 2017-2028
5 Sights By Application
    5.1 Overview
        5.1.1 By Application - Global Alpha Galactosidase A Market Size, 2021 & 2028
        5.1.2 Hospital
        5.1.3 Clinic
        5.1.4 Home Care
    5.2 By Application - Global Alpha Galactosidase A Revenue & Forecasts
        5.2.1 By Application - Global Alpha Galactosidase A Revenue, 2017-2022
        5.2.2 By Application - Global Alpha Galactosidase A Revenue, 2023-2028
        5.2.3 By Application - Global Alpha Galactosidase A Revenue Market Share, 2017-2028
    5.3 By Application - Global Alpha Galactosidase A Sales & Forecasts
        5.3.1 By Application - Global Alpha Galactosidase A Sales, 2017-2022
        5.3.2 By Application - Global Alpha Galactosidase A Sales, 2023-2028
        5.3.3 By Application - Global Alpha Galactosidase A Sales Market Share, 2017-2028
    5.4 By Application - Global Alpha Galactosidase A Price (Manufacturers Selling Prices), 2017-2028
6 Sights by Region
    6.1 By Region - Global Alpha Galactosidase A Market Size, 2021 & 2028
    6.2 By Region - Global Alpha Galactosidase A Revenue & Forecasts
        6.2.1 By Region - Global Alpha Galactosidase A Revenue, 2017-2022
        6.2.2 By Region - Global Alpha Galactosidase A Revenue, 2023-2028
        6.2.3 By Region - Global Alpha Galactosidase A Revenue Market Share, 2017-2028
    6.3 By Region - Global Alpha Galactosidase A Sales & Forecasts
        6.3.1 By Region - Global Alpha Galactosidase A Sales, 2017-2022
        6.3.2 By Region - Global Alpha Galactosidase A Sales, 2023-2028
        6.3.3 By Region - Global Alpha Galactosidase A Sales Market Share, 2017-2028
    6.4 North America
        6.4.1 By Country - North America Alpha Galactosidase A Revenue, 2017-2028
        6.4.2 By Country - North America Alpha Galactosidase A Sales, 2017-2028
        6.4.3 US Alpha Galactosidase A Market Size, 2017-2028
        6.4.4 Canada Alpha Galactosidase A Market Size, 2017-2028
        6.4.5 Mexico Alpha Galactosidase A Market Size, 2017-2028
    6.5 Europe
        6.5.1 By Country - Europe Alpha Galactosidase A Revenue, 2017-2028
        6.5.2 By Country - Europe Alpha Galactosidase A Sales, 2017-2028
        6.5.3 Germany Alpha Galactosidase A Market Size, 2017-2028
        6.5.4 France Alpha Galactosidase A Market Size, 2017-2028
        6.5.5 U.K. Alpha Galactosidase A Market Size, 2017-2028
        6.5.6 Italy Alpha Galactosidase A Market Size, 2017-2028
        6.5.7 Russia Alpha Galactosidase A Market Size, 2017-2028
        6.5.8 Nordic Countries Alpha Galactosidase A Market Size, 2017-2028
        6.5.9 Benelux Alpha Galactosidase A Market Size, 2017-2028
    6.6 Asia
        6.6.1 By Region - Asia Alpha Galactosidase A Revenue, 2017-2028
        6.6.2 By Region - Asia Alpha Galactosidase A Sales, 2017-2028
        6.6.3 China Alpha Galactosidase A Market Size, 2017-2028
        6.6.4 Japan Alpha Galactosidase A Market Size, 2017-2028
        6.6.5 South Korea Alpha Galactosidase A Market Size, 2017-2028
        6.6.6 Southeast Asia Alpha Galactosidase A Market Size, 2017-2028
        6.6.7 India Alpha Galactosidase A Market Size, 2017-2028
    6.7 South America
        6.7.1 By Country - South America Alpha Galactosidase A Revenue, 2017-2028
        6.7.2 By Country - South America Alpha Galactosidase A Sales, 2017-2028
        6.7.3 Brazil Alpha Galactosidase A Market Size, 2017-2028
        6.7.4 Argentina Alpha Galactosidase A Market Size, 2017-2028
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Alpha Galactosidase A Revenue, 2017-2028
        6.8.2 By Country - Middle East & Africa Alpha Galactosidase A Sales, 2017-2028
        6.8.3 Turkey Alpha Galactosidase A Market Size, 2017-2028
        6.8.4 Israel Alpha Galactosidase A Market Size, 2017-2028
        6.8.5 Saudi Arabia Alpha Galactosidase A Market Size, 2017-2028
        6.8.6 UAE Alpha Galactosidase A Market Size, 2017-2028
7 Manufacturers & Brands Profiles
    7.1 Amicus Therapeutics, Inc.
        7.1.1 Amicus Therapeutics, Inc. Corporate Summary
        7.1.2 Amicus Therapeutics, Inc. Business Overview
        7.1.3 Amicus Therapeutics, Inc. Alpha Galactosidase A Major Product Offerings
        7.1.4 Amicus Therapeutics, Inc. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.1.5 Amicus Therapeutics, Inc. Key News
    7.2 Greenovation Biotech GmbH
        7.2.1 Greenovation Biotech GmbH Corporate Summary
        7.2.2 Greenovation Biotech GmbH Business Overview
        7.2.3 Greenovation Biotech GmbH Alpha Galactosidase A Major Product Offerings
        7.2.4 Greenovation Biotech GmbH Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.2.5 Greenovation Biotech GmbH Key News
    7.3 iBio, Inc.
        7.3.1 iBio, Inc. Corporate Summary
        7.3.2 iBio, Inc. Business Overview
        7.3.3 iBio, Inc. Alpha Galactosidase A Major Product Offerings
        7.3.4 iBio, Inc. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.3.5 iBio, Inc. Key News
    7.4 ISU ABXIS Co.,Ltd.
        7.4.1 ISU ABXIS Co.,Ltd. Corporate Summary
        7.4.2 ISU ABXIS Co.,Ltd. Business Overview
        7.4.3 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Major Product Offerings
        7.4.4 ISU ABXIS Co.,Ltd. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.4.5 ISU ABXIS Co.,Ltd. Key News
    7.5 JCR Pharmaceuticals Co., Ltd.
        7.5.1 JCR Pharmaceuticals Co., Ltd. Corporate Summary
        7.5.2 JCR Pharmaceuticals Co., Ltd. Business Overview
        7.5.3 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Major Product Offerings
        7.5.4 JCR Pharmaceuticals Co., Ltd. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.5.5 JCR Pharmaceuticals Co., Ltd. Key News
    7.6 Pharming Group N.V.
        7.6.1 Pharming Group N.V. Corporate Summary
        7.6.2 Pharming Group N.V. Business Overview
        7.6.3 Pharming Group N.V. Alpha Galactosidase A Major Product Offerings
        7.6.4 Pharming Group N.V. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.6.5 Pharming Group N.V. Key News
    7.7 Protalix BioTherapeutics, Inc.
        7.7.1 Protalix BioTherapeutics, Inc. Corporate Summary
        7.7.2 Protalix BioTherapeutics, Inc. Business Overview
        7.7.3 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Major Product Offerings
        7.7.4 Protalix BioTherapeutics, Inc. Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.7.5 Protalix BioTherapeutics, Inc. Key News
    7.8 Takeda
        7.8.1 Takeda Corporate Summary
        7.8.2 Takeda Business Overview
        7.8.3 Takeda Alpha Galactosidase A Major Product Offerings
        7.8.4 Takeda Alpha Galactosidase A Sales and Revenue in Global (2017-2022)
        7.8.5 Takeda Key News
8 Global Alpha Galactosidase A Production Capacity, Analysis
    8.1 Global Alpha Galactosidase A Production Capacity, 2017-2028
    8.2 Alpha Galactosidase A Production Capacity of Key Manufacturers in Global Market
    8.3 Global Alpha Galactosidase A Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Alpha Galactosidase A Supply Chain Analysis
    10.1 Alpha Galactosidase A Industry Value Chain
    10.2 Alpha Galactosidase A Upstream Market
    10.3 Alpha Galactosidase A Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Alpha Galactosidase A Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

NEED Help?

If you need any help or guidance, please feel free to call us.

USA : +1 (661) 636 6162

INDIA : +91 9325802062

or

Write us on : sales@kandjmarketresearch.com